Results of prostate biopsies in a teaching hospital in Western Saudi Arabia

Saudi Medical Journal

Volumn 24, Issue 8, 2003, Pages 859-862

  Tayib, Abdulmalik M ^a   Mosli, Hisham A ^a   Al Ammari, Adel A ^a  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RESEARCH; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FREQUENCY ANALYSIS; HUMAN; HUMAN TISSUE; MALE; MEDICAL RECORD; PATIENT SELECTION; PHYSICAL EXAMINATION; PROSTATE BIOPSY; PROSTATE CANCER; SAMPLE SIZE; SAUDI ARABIA; TEACHING HOSPITAL; TRANSRECTAL ULTRASONOGRAPHY; UNIVERSITY HOSPITAL;

ADULT; AGE DISTRIBUTION; AGED; BIOPSY, NEEDLE; ENDOSONOGRAPHY; HOSPITALS, TEACHING; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PALPATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SAUDI ARABIA; SENSITIVITY AND SPECIFICITY;

EID: 0141592483     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Djavan B, Remzi M, Schulman CC, Marberger M, Zlotta AR. Repeat prostate biopsy: who, how and when?. A review. Eur Urol 2002; 42: 93-103.
2. Neil F, Maryellen O, Fair W. Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol 1997; 158: 505-509.
3. Djavan B, Mazzal P, Zlotta A, Wammack R, Ravery V, Remzi M et al. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the Prospective European Prostate Detection study. Prostate 2001; 47: 111-117.
4. Gunnar A, Svante B, Jonas H, Par Carl G, Erik P. Outcome of laterally directed sextant biopsies of the prostate in screened males aged 50-66 years. Eur Urol 2001; 39: 655-661.
5. Joseph C, Presti J, James J, Chang Vivek B, Katsuto S. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: Results of a Prospective clinical trial. J Urol 2000; 163: 163-167.
6. Babaian J, Ants T, Kazumi K, Patricia T, Joan S, Evans R et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000; 163: 152-157.
7. Applewhite JC, Matlaga BR, McCullough DL, Hall MC. Transrectal ultrasound and Biopsy in the early diagnosis of prostate cancer. Cancer Control 2001; 2: 141-150.
8. Sedelaar JP, Vijverberg PL, De Reijke TM, De La Rossette JJ, Kil PJ, Braeckman JG et al. Transrectal ultrasound in the diagnosis of prostate cancer: state of art and perspectives. Eur Urol 2001; 40: 275-284.
9. Veltman J, Tjerk G, Pilar L, Hessel W, De La Rosette J. New technical improvement for TRUS in the diagnosis Eur Urol 2002; 1: 8-14.
10. Morote J, Enrique T, Salvador E, Francesc S, Jose MA, Aurelio M et al. The percentage of free prostatic specific antigen is also useful in men with normal digital rectal examination and PSA between 10.1 and 20ng/ml. Eur Urol 2002; 42: 333-337.
11. Catalona WJ, Jerome P, Richie, Frederick R, Ahmann M, Liss A et al. Comparison of digital rectal examination and serum PSA in the early detection of prostate cancer:results of a multicenter clinical trial 6,630 men. J Urol 1994; 151: 1283-1290.
12. Cooner WH, Mosley BR, Charles L, Rutherford JR, Jeff H. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 1989; 143: 1146-1151.
13. Yurdakul G, Bangma C, Blijenberg BG, Van Zelst BD, Wildhagen, Van Kwast TH et al. Different PSA assays lead to detection of prostate cancers with identical histological features. Eur Urol 2002; 42: 154-158.
14. Richardson TD, Oesterling JE. Age-Specific Reference ranges for serum prostate specific antigen. Urol Clin North Am 1997; 24: 339-350.
15. Mosli HA. Prostate cancer in Saudi Arabia, review of the literature (1975-1996). Annals of Saudi Medicine 1997; 17: 510-514.
16. Vanderkerken J, De La Rosette J, Pilar L, Debruyne F. How and when to take Prostate Biopsies. Eur Urol 2002; 1: 15-20.
17. Hodge KK, McNeal J, Terris MK, Stamey T. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989: 142: 71-75.
18. Alhazmi H, Abomelha MS, Said MT, Orkubi SA, The detection rate of DRE and PSA in Prostate Cancer, Results of 175 patients with Prostatic biopsies. Proceedings of the 14th Saudi Urological Conference; 2001 Feb 13-15; Dhahran, Kingdom of Saudi Arabia.
19. Alotaibi KM, Altartir T, Trabulsi FM. Predictive parameters in screening for Prostate Cancer. Proceedings of the 14th Saudi Urological Conference; 2001 Feb 13-15; Dhahran, Kingdom of Saudi Arabia.
20. Gretzer MB, Partin AW. PSA Levels and the Probability of Prostate Cancer on Biopsy. Eur Urol 2002; 1: 21-27.
21. Mosli HA, Prostate Cancer experience at King Abdulaziz University Hospital. Annals of Saudi Medicine 1997; 17: 590-594.
22. Mosli HA. Incidental Adenocarcinoma of the Prostate, Frequency rate at tertiary care Hospital. Annals of Saudi Medicine 1997; 17: 662-664.